For more than three decades, Jensen Huang has been the face of NVIDIA. He wasn't just the CEO of the company powering the AI revolution. He was also its chief strategist, dealmaker, industry spokesperson and one of the most influential figures in the global semiconductor ecosystem. Now, that era has come to an abrupt end. On November 12, NVIDIA officially announced that Jensen Huang had resigned as President, CEO and a member of the Board, effective immediately. CFO Colette Kress has been appointed interim CEO, while the board begins searching for a permanent successor. Harvey C. Jones has also been appointed NVIDIA's first-ever Board Chair. This is a major leadership transition for one of the world's most important technology companies. And the market reaction was immediate. On Thursday,

Pretty wild turnaround for AI infrastructure stocks. $CoreWeave, Inc.(CRWV)$ $NEBIUS(NBIS)$ Just a few days ago, everyone seemed worried about excessive AI spending, rising debt and whether data center investments could ever generate enough returns. Then CoreWeave ($CRWV) reported earnings, and suddenly the market was buying AI infrastructure stocks again. On November 11, CRWV jumped 24.7%. Nebius ($NBIS) gained 15.4%, Applied Digital ($APLD) rose 7.4%, and NVIDIA ($NVDA) was up 2.9%. The Philadelphia Semiconductor Index also rallied 5.7%. So what changed? CoreWeave reported $3.66 billion in Q3 revenue, up 168% year over year, with revenue backlog reaching an incredible $13

Didn't expect NVIDIA's biggest headline this week to have nothing to do with GPUs. $英伟达(NVDA)$ On November 8, NVIDIA's board announced an independent investigation following reports that CEO Jensen Huang may have been targeted by a foreign intelligence operation. Two days later, the company confirmed that it had hired former federal prosecutor Joon H. Kim and his law firm to conduct the investigation. According to Reuters, NVIDIA lost roughly $430 billion in market value over two trading sessions, with shares down about 9.5% since the controversy began. That's an enormous amount of value disappearing in just a couple of days. But what interests me more isn't the scandal itself. It's what this situation tells us about NVIDIA's gover

Pretty interesting couple of days for Anthropic. $Anthropic(ANT)$ On November 9, the company introduced Claude Fable 5.2 and Mythos 5.2, showing another major leap in coding, AI agents and complex problem-solving. Then, just a day later, Reuters reported that Anthropic had withdrawn preliminary IPO pricing information circulated to banks because some of the details were inaccurate. The withdrawn materials reportedly included a $70–$80 share price range and a potential offering size of up to $69.3 billion. To be clear, Anthropic hasn't withdrawn its IPO application. The pricing information was retracted, and those numbers shouldn't be treated as confirmed offering terms. But the pricing issue isn't really what interests me most. What

Just as Wall Street was recovering from last week's dramatic selloff, another major market catalyst emerged. The latest U.S. jobs report came in much stronger than expected, pushing market expectations for a December Federal Reserve rate hike sharply higher. According to the Bureau of Labor Statistics, the U.S. economy added 165,000 jobs in October, compared with economists' expectations of approximately 65,000. The unemployment rate fell to 4.1%, while average hourly earnings increased 0.4% month over month. Following the report, traders raised their expectations for a December rate hike. By November 9, market-implied odds of a 25-basis-point increase had reached approximately 80%. And the next major test is just around the corner. The U.S. October CPI report will be released on November

The U.S. midterm elections are over, but the real policy battle is only beginning. On November 4, following the Democrats' victory in both chambers of Congress, House Democratic leader Hakeem Jeffries outlined an ambitious agenda for the next Congress. The priorities are clear: restore Affordable Care Act (ACA) subsidies, reverse Medicaid spending cuts, challenge Trump's tariffs, and ban members of Congress from trading individual stocks. And Wall Street is already reacting. On November 4, the Dow Jones Industrial Average surged 3%, the S&P 500 gained 1.6%, and the Nasdaq Composite rose 1.4%. Healthcare stocks were among the most interesting movers. Centene jumped approximately 12.6%, while Molina Healthcare climbed around 8.9%, as investors began pricing in potential changes to federa

The U.S. midterm elections have delivered a dramatic political shift, and Wall Street is already reacting. On November 4, as Democrats secured control of both chambers of Congress, U.S. stock futures initially came under heavy selling pressure. Nasdaq-100 futures fell roughly 2%, while S&P 500 futures dropped as much as 1.2%. Asian semiconductor stocks also declined as investors reassessed the potential impact of a new political landscape on AI infrastructure and technology regulation. But the selloff did not last at the same intensity. As trading continued, Nasdaq-100 futures recovered significantly, narrowing their losses to around 0.7%, while S&P 500 futures also regained part of their earlier decline. Within hours, the market shifted from aggressive selling to a sharp rebound.

Apple delivered revenue and earnings per share above expectations, but its shares still came under pressure after the report. On November 2, Apple reported fiscal fourth-quarter 2026 results for the period ended September 26. Revenue reached approximately $114.5 billion, up 12% year over year, with EPS of $2.10. CNBC cited LSEG consensus estimates of $113.39 billion and $1.99, respectively, and reported that shares fell approximately 3% at one point in November 2 after-hours trading. This was John Ternus’s first earnings report as CEO. Apple posted a September-quarter revenue record, iPhone sales continued to grow, and services revenue reached an all-time high.[1][2] The next quarter’s outlook, however, contained an important split: revenue growth guidance exceeded expectations, while gros

Alphabet fell more than 12% in one day, and several technology heavyweights are 20%-30% below their 2026 closing highs. That has brought the familiar buying-the-dip question back into focus. Tiger's view: It is reasonable to start screening profitable companies after these pullbacks, but there is not enough evidence to declare a bottom across technology stocks. Prices, earnings and cash flow need to be assessed together—and historical recoveries show why the time horizon matters. 01 | Stock-level selloffs and index drawdowns differ On October 29, the Nasdaq Composite closed at 26,184.72, down 1.38%. The Nasdaq-100 fell 1.38%, while the S&P 500 lost 0.30%. GOOGL dropped 12.64%, Amazon fell 4.25%, Microsoft slipped just 0.16%, and Meta rose 1.96%. The performance was sharply divided. [1]

Memory chips, oil prices, Treasury yields and corporate earnings can seem like separate stories. Their connections become clearer when you trace how demand becomes revenue—and how much of that revenue ultimately turns into cash. Focus on the sources of growth, the spending needed to support it, and the cash left over. Valuation then helps explain why companies exposed to the same theme can offer different opportunities and risks. Here are the nine themes in our accompanying graphic, with a closer look at what to track. 01 | Memory: Read demand, pricing and capacity together For AI-related memory demand, watch whether orders become revenue, whether pricing supports margins, and when new capacity comes online. The relative pace of demand growth and supply expansion helps determine how long f

Elon Musk has raised a question for AI infrastructure investors: if demand keeps growing, why might some cloud providers struggle to survive? In an X post on October 25 U.S. time, Musk said debt markets had largely closed to companies without substantial revenue outside AI data centers. He said SpaceX had completed $40 billion in GPU debt financing, pointing to what he described as its investment-grade credit standing and revenue from Starlink and rocket launches. He then predicted widespread failures and consolidation among more than 200 neocloud companies, with relatively few making it through. Those statements about financing conditions, the number of providers, and their prospects are Musk’s assessment—not independently verified industry-wide findings. He did not specify a failure rate

The AI trade is facing one of its biggest tests yet. Last week, the Philadelphia Semiconductor Index fell roughly 11%, as investors grew increasingly concerned about AI infrastructure financing, elevated valuations and whether massive capital spending could eventually generate sufficient returns. Yet just as Wall Street begins questioning the economics of AI, Meta is preparing to report its Q3 earnings on October 21. And the company has already outlined an extraordinary spending plan: $130 billion to $145 billion in capital expenditures for 2026. That creates an interesting contradiction. AI infrastructure stocks are getting punished for spending too much, while Meta is preparing to defend one of the largest AI investment programs in the industry. So the real question going into earnings i

After nearly nine years of waiting, Tesla has finally unveiled its next-generation Roadster. And this time, it is not just another electric supercar. At an October 15 event in Texas, Tesla demonstrated a Roadster equipped with SpaceX-developed thruster technology, capable of briefly lifting off the ground, performing aerial maneuvers and even driving upside down using a specialized suction system. The company also showcased a 0–60 mph acceleration time of just 0.81 seconds and claimed a potential top speed exceeding 230 mph. Those are extraordinary numbers, although the demonstration results have not yet been independently verified for a production vehicle. The real question, however, is not whether Tesla has built a car that can briefly fly. It is why Elon Musk is promoting an extreme, hu

U.S. stocks showed a striking divergence in the latest trading session. The Nasdaq fell 1.88%, while the Philadelphia Semiconductor Index dropped 4.3%, marking its sixth consecutive daily decline. Oracle plunged nearly 9%, CoreWeave lost around 15%, and several AI infrastructure names remained under heavy pressure. Meanwhile, healthcare and consumer staples moved in the opposite direction, gaining approximately 2.4% and 2.1%, respectively, during the session. Traditional defensive names such as Procter & Gamble and Johnson & Johnson attracted renewed interest. On the same day AI stocks were being sold aggressively, companies selling everyday essentials and healthcare products were finding buyers. The interesting question is not simply why technology stocks fell. It is why investors